Lv11
20 积分 2025-09-29 加入
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
1个月前
已完结
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13
1个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
3个月前
已完结
The role of complement in kidney disease
4个月前
已完结
[Expert consensus on postoperative pathological diagnosis of thyroid cancer (version 2025)]
5个月前
已完结
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
7个月前
已完结
Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer
8个月前
已完结
Mechanisms of Resistance to Tyrosine Kinase Inhibitors in ROS1 Fusion-Positive Nonsmall Cell Lung Cancer
8个月前
已完结
BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives
9个月前
已完结
Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma
9个月前
已完结
皖公网安备34019202002308
